No significant demographic or phenotypic differences were found between HLA-DQA1*05 carriers versus non-carriers, in either treatment group.
Alex McCarthy, PharmD
Advertisement
Articles by Alex McCarthy, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Single-Center Experience With Vorasidenib in Patients With Grade 3 or 4 IDH-Mutant Gliomas
2
McKesson ideaShare 2026: Recapping Key Insights from Denver
3
The Human Element: Building Relationships and Empathy in a Busy Pharmacy
4
Personalized Cancer Vaccines and Immunotherapy Advance Melanoma Care
5